Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 822.40 INR
Change Today +8.15 / 1.00%
Volume 3.5M
SUNP On Other Exchanges
Symbol
Exchange
Natl India
OTC US
As of 7:06 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

sun pharmaceutical indus (SUNP) Snapshot

Open
819.00
Previous Close
814.25
Day High
825.30
Day Low
812.00
52 Week High
04/7/15 - 1,201
52 Week Low
08/8/14 - 743.25
Market Cap
2.0T
Average Volume 10 Days
7.4M
EPS TTM
21.92
Shares Outstanding
2.4B
EX-Date
09/11/14
P/E TM
37.5x
Dividend
1.50
Dividend Yield
0.18%
Current Stock Chart for SUN PHARMACEUTICAL INDUS (SUNP)

Related News

No related news articles were found.

sun pharmaceutical indus (SUNP) Related Businessweek News

View More BusinessWeek News

sun pharmaceutical indus (SUNP) Details

Sun Pharmaceutical Industries Limited, a specialty pharmaceutical company, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, such as psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics, ophthalmology, diabetology, musculo-skeletal and pain, gynecology, and urology, as well as antiasthamatic and antiallergic. It also provides APIs comprising anticancers, peptides, sex hormones, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.

Founded in 1983

sun pharmaceutical indus (SUNP) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: 23.1M
Wholetime Director and Member of Shareholders...
Total Annual Compensation: 23.1M
Whole Time Director
Total Annual Compensation: 8.5M
Compensation as of Fiscal Year 2014.

sun pharmaceutical indus (SUNP) Key Developments

Sun Pharmaceutical Industries Cuts Staff

Sun Pharmaceutical Industries is cutting staff again as it digests the $3.2 billion acquisition of Ranbaxy Laboratories. Close to 15 employees from the R&D department are to exit as Sun integrates a combined staff base that's 30,000 strong. Sun also said that to achieve long-term synergy, the company will look at selling low-margin, non-strategic businesses such as the active pharmaceutical ingredients (API) division.

Sun Pharmaceutical Industries Limited, Board Meeting, Jul 23, 2015

Sun Pharmaceutical Industries Limited, Board Meeting, Jul 23, 2015. Agenda: To allot 72,789 equity shares of the company of INR 1 each on exercise or stock options under the Sun Employee Stock Option Scheme - 2015.

Sun Pharmaceutical Industries Limited - Special Call

To discuss business update

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SUNP:IN 822.40 INR +8.15

SUNP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cipla Ltd/India 709.05 INR -2.00
Endo International PLC $87.54 USD +1.58
Hospira Inc $89.45 USD +0.05
Mylan NV $55.99 USD -0.36
Perrigo Co PLC $192.20 USD +0.77
View Industry Companies
 

Industry Analysis

SUNP

Industry Average

Valuation SUNP Industry Range
Price/Earnings 42.4x
Price/Sales 7.1x
Price/Book 7.3x
Price/Cash Flow 33.0x
TEV/Sales 6.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUN PHARMACEUTICAL INDUS, please visit www.sunpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.